Add to a list

Inactive Instrument

Cognetivity Neurosciences Ltd. Share Price Canadian Securities Exchange

CGN

CA19243C1005

Advanced Medical Equipment & Technology

OTC Markets Traded

Valuation: Cognetivity Neurosciences Ltd.

Market Cap	1.2M 848K 744K 689K 634K 81.14M 1.22M 8.21M 3.22M 39.85M 3.18M 3.11M 138M	P/E 2022	-2.9x	P/E 2023	-2.8x
Enterprise Value	245K 173K 152K 141K 130K 16.6M 250K 1.68M 659K 8.15M 651K 637K 28.15M	EV / Sales 2022	-	EV / Sales 2023	437,922,999x
Free-Float	85.56%	Yield 2022 *	-	Yield 2023	-

* Estimated data More valuation ratios

Managers and Directors: Cognetivity Neurosciences Ltd.

Manager	Title	Age	Since
Sina Habibi CEO	Chief Executive Officer	45	31/03/2013
Mark Phillips CMP	Compliance Officer	67	20/12/2017

Director	Title	Age	Since
Sina Habibi BRD	Director/Board Member	45	31/12/2016
Mark Phillips BRD	Director/Board Member	67	20/12/2017

More insiders

Medical Software & Technology Services

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
COGNETIVITY NEUROSCIENCES LTD.	-.--%	-33.33%	-	-	93
VEEVA SYSTEMS INC.	+3.52%	+2.50%	-28.66%	-5.72%	30.88B
PRO MEDICUS LIMITED	-3.81%	-9.36%	-39.74%	+191.66%	14.32B
SECTRA AB	+1.42%	-2.52%	-20.49%	+73.05%	5.64B
HEARTFLOW, INC.	-2.10%	-3.50%	-	-	2.3B
OMNICELL, INC.	+3.92%	+3.18%	+62.70%	-36.39%	2.04B
GENERATE BIOMEDICINES, INC.	-0.31%	-15.60%	-	-	1.84B
XUNFEI HEALTHCARE TECHNOLOGY CO., LTD.	-1.91%	-2.80%	-31.22%	-	1.09B
ARBUTUS BIOPHARMA CORPORATION	-2.81%	-6.14%	+47.16%	+105.51%	948M
RAYSEARCH LABORATORIES AB	-0.94%	+0.78%	-33.39%	+252.82%	832M
Average	-0.32%	-4.52%	-6.23%	+96.82%	6.66B
Weighted average by Cap.	+0.94%	-3.33%	-26.17%	+58.83%

See all sector performances

Cognetivity Neurosciences Ltd. is a Canada-based technology company. The Company has developed a cognitive testing platform, the Integrated Cognitive Assessment (ICA), for use in medical and commercial environments and other neurological conditions. The Companyâ€™s CognICA uses artificial intelligence and machine learning technology to test the performance of large areas of the brain to help detect early signs of cognitive dysfunction. It is also focused on developing the ICA for home use, for the remote monitoring of patientâ€™s progress under treatment regimens and for general home healthcare check-ups. CognICA is available for clinical use in the United States, United Kingdom, Europe, Canada and the Middle East. Its subsidiaries include Cognetivity Ltd. and Cognetivity FZ-LLC.

Employees

Sector

Advanced Medical Equipment & Technology

More about the company

Google lets you customize your preferred sources.

Choose MarketScreener

	2022	2023
Net sales	-	0.05 0.03 0.03 0.03 0.02 3.07 0.05 0.31 0.12 1.51 0.12 0.12 5.21
Net income	-13.13M -9.29M -8.14M -7.54M -6.94M -889M -13.38M -89.9M -35.26M -436M -34.87M -34.1M -1.51B	-7.43M -5.26M -4.61M -4.27M -3.93M -503M -7.58M -50.91M -19.97M -247M -19.74M -19.31M -854M
Net Debt	-82.43K -58.3K -51.14K -47.36K -43.58K -5.58M -84.03K -565K -221K -2.74M -219K -214K -9.46M	-953K -674K -591K -548K -504K -64.55M -972K -6.53M -2.56M -31.7M -2.53M -2.48M -109M

Cognetivity Neurosciences Ltd. Share Price Canadian Securities Exchange

Stocks

CGN

CA19243C1005

Advanced Medical Equipment & Technology

Valuation: Cognetivity Neurosciences Ltd.

Managers and Directors: Cognetivity Neurosciences Ltd.

Medical Software & Technology Services

Financials

Company Profile